Search for Clinical Trial Results
Lupus Erythematosus, Discoid - 22 Studies Found
Status | Study |
Terminated |
Study Name: A Research Study to Assess if CC-930 is Safe in Treating Subjects With Discoid Lupus Erythematosus Condition: Discoid Lupus Date: 2011-11-04 Interventions:
|
Completed |
Study Name: Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions Condition:
Date: 2012-05-09 Interventions: |
Completed |
Study Name: Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions Condition: Discoid Lupus Erythematosus Date: 2008-02-20 Interventions:
|
Completed |
Study Name: Comparing the Therapeutic Efficacy of Pimecrolimus Cream With Betamethasone Cream for Discoid Lupus Erythematosus Condition: Discoid Lupus Erythematosus Date: 2008-01-23 Interventions:
|
Terminated |
Study Name: Discoid Lupus Erythematosus of the Scalp and a Trial of Biologic Therapy With Raptiva Condition: Discoid Lupus Erthematosus of the Scalp. Date: 2006-03-28 Interventions: Drug: Raptiva (efalizumab) |
Completed |
Study Name: A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus Condition: Discoid Lupus Erythematosus Date: 1999-11-03 Interventions: Drug: Thalidomide |
Completed |
Study Name: Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions (2) Condition: Discoid Lupus Erythematosus Date: 2008-02-20 Interventions:
|
Completed |
Study Name: The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus Erythematosus Condition: Discoid Lupus Erythematosus (DLE) Date: 2008-11-21 Interventions: Drug: etanercept(Enbrel®) etanercept(Enbrel®) 50mgs subcutaneous (SC) injections twice weekly |
Recruiting |
Study Name: Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus Condition:
Interventions: Drug: Etanercept Treatment with etanercept is intended for remission induction of DLE only and not for m |
Recruiting |
Study Name: Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Condition:
Date: 2017-05-02 Interventions: Biological: Tofacitinib citrate 10 mg daily by mouth |